234 related articles for article (PubMed ID: 15629137)
1. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes.
Kim KY; Kim JK; Jeon JH; Yoon SR; Choi I; Yang Y
Biochem Biophys Res Commun; 2005 Feb; 327(2):460-7. PubMed ID: 15629137
[TBL] [Abstract][Full Text] [Related]
2. GO6976 prevents TNF-alpha-induced suppression of adiponectin expression in 3T3-L1 adipocytes: putative involvement of protein kinase C.
Lim JY; Kim WH; Park SI
FEBS Lett; 2008 Oct; 582(23-24):3473-8. PubMed ID: 18804108
[TBL] [Abstract][Full Text] [Related]
3. JNK- and IkappaB-dependent pathways regulate MCP-1 but not adiponectin release from artificially hypertrophied 3T3-L1 adipocytes preloaded with palmitate in vitro.
Takahashi K; Yamaguchi S; Shimoyama T; Seki H; Miyokawa K; Katsuta H; Tanaka T; Yoshimoto K; Ohno H; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E898-909. PubMed ID: 18303122
[TBL] [Abstract][Full Text] [Related]
4. Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase.
Huypens P; Quartier E; Pipeleers D; Van de Casteele M
Eur J Pharmacol; 2005 Aug; 518(2-3):90-5. PubMed ID: 16039647
[TBL] [Abstract][Full Text] [Related]
5. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
6. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha.
Kita A; Yamasaki H; Kuwahara H; Moriuchi A; Fukushima K; Kobayashi M; Fukushima T; Takahashi R; Abiru N; Uotani S; Kawasaki E; Eguchi K
Biochem Biophys Res Commun; 2005 Jun; 331(2):484-90. PubMed ID: 15850785
[TBL] [Abstract][Full Text] [Related]
7. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.
Fasshauer M; Klein J; Neumann S; Eszlinger M; Paschke R
Biochem Biophys Res Commun; 2002 Jan; 290(3):1084-9. PubMed ID: 11798186
[TBL] [Abstract][Full Text] [Related]
8. Effect of PPARalpha activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes.
Murakami K; Bujo H; Unoki H; Saito Y
Eur J Pharmacol; 2007 Apr; 561(1-3):206-13. PubMed ID: 17320860
[TBL] [Abstract][Full Text] [Related]
9. Brazilian propolis-derived components inhibit TNF-α-mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes.
Ikeda R; Yanagisawa M; Takahashi N; Kawada T; Kumazawa S; Yamaotsu N; Nakagome I; Hirono S; Tsuda T
Biochim Biophys Acta; 2011 Jul; 1810(7):695-703. PubMed ID: 21554928
[TBL] [Abstract][Full Text] [Related]
10. Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells.
Garcia-Macedo R; Sanchez-Muñoz F; Almanza-Perez JC; Duran-Reyes G; Alarcon-Aguilar F; Cruz M
Eur J Pharmacol; 2008 Jun; 587(1-3):317-21. PubMed ID: 18499099
[TBL] [Abstract][Full Text] [Related]
11. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes.
Bao Y; Bing C; Hunter L; Jenkins JR; Wabitsch M; Trayhurn P
FEBS Lett; 2005 Jan; 579(1):41-7. PubMed ID: 15620688
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes.
Xu A; Wong LC; Wang Y; Xu JY; Cooper GJ; Lam KS
FEBS Lett; 2004 Aug; 572(1-3):129-34. PubMed ID: 15304336
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes.
Araki S; Dobashi K; Kubo K; Yamamoto Y; Asayama K; Shirahata A
Life Sci; 2006 Nov; 79(25):2405-12. PubMed ID: 16952378
[TBL] [Abstract][Full Text] [Related]
14. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α.
Kameji H; Mochizuki K; Miyoshi N; Goda T
Nutrition; 2010; 26(11-12):1151-6. PubMed ID: 20097535
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
16. Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
Jones SP; Janneh O; Back DJ; Pirmohamed M
Antivir Ther; 2005; 10(2):207-13. PubMed ID: 15865214
[TBL] [Abstract][Full Text] [Related]
17. Glimepiride enhances intrinsic peroxisome proliferator-activated receptor-gamma activity in 3T3-L1 adipocytes.
Inukai K; Watanabe M; Nakashima Y; Takata N; Isoyama A; Sawa T; Kurihara S; Awata T; Katayama S
Biochem Biophys Res Commun; 2005 Mar; 328(2):484-90. PubMed ID: 15694373
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
[TBL] [Abstract][Full Text] [Related]
19. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
Nakano S; Inada Y; Masuzaki H; Tanaka T; Yasue S; Ishii T; Arai N; Ebihara K; Hosoda K; Maruyama K; Yamazaki Y; Shibata N; Nakao K
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
